Structure Therapeutics Inc. American Depositary Shares — informes financieros trimestrales (NASDAQ:GPCR) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Market Capitalization 3.8432 B
Employee 220
Founded 2016
CEO N/A
Website www.structuretx.com
Headquarter Cayman Islands
FIGI BBG01CBVHLW1
Industry Biotecnología

Ingresos totales

Beneficio neto

Beneficio básico por acción

Deuda total

Flujo de caja libre

Efectivo y equivalentes

3.84 B Capitalización de mercado

Noticias

Leerink mantiene la calificación de Mejor Rendimiento para Structure Therapeutics

Structure Therapeutics nombra a Matthew Lang como COO y asesor legal

Does NVO Face Rising Competitive Pressure on LLY's Foundayo Approval?

Structure Therapeutics: The Oral Obesity Inflection, Best-In-Class Efficacy

Structure Therapeutics: A High-Risk, High-Reward Bet On The Next GLP-1 Blockbuster (GPCR)

Wolfe Research inicia cobertura de Structure Therapeutics con calificación Peerperform

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?

Eli Lilly's Experimental Drug Retatrutide Delivers Strong Weight Loss In Late-Stage Trial

Why Did Eli Lilly Stock Slide 6% Despite Strong GLP-1 Momentum?

BMO eleva el precio objetivo de Structure Therapeutics por datos de fármaco para obesidad

BMO raises Structure Therapeutics stock price target on obesity drug data

Structure Therapeutics' GLP-1 Agonist Could Be A Potential Acquisition Target (GPCR)